Compare MDXG & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | XRX |
|---|---|---|
| Founded | 2006 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 340.6M |
| IPO Year | N/A | N/A |
| Metric | MDXG | XRX |
|---|---|---|
| Price | $5.43 | $2.72 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $11.00 | $3.50 |
| AVG Volume (30 Days) | 931.7K | ★ 2.7M |
| Earning Date | 02-25-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.68% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | $393,442,000.00 | ★ $6,607,000,000.00 |
| Revenue This Year | $19.13 | $15.48 |
| Revenue Next Year | $2.11 | $11.05 |
| P/E Ratio | $20.07 | ★ N/A |
| Revenue Growth | ★ 14.77 | 3.67 |
| 52 Week Low | $5.39 | $2.32 |
| 52 Week High | $9.36 | $9.91 |
| Indicator | MDXG | XRX |
|---|---|---|
| Relative Strength Index (RSI) | 21.91 | 56.30 |
| Support Level | $5.55 | $2.44 |
| Resistance Level | $6.50 | $2.73 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 2.55 | 91.67 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.